Strong influence of the ancillary ligand over the photodynamic anticancer properties of neutral biscyclometalated IrIII complexes bearing 2‐benzoazole‐phenolates by Martínez Alonso, Marta et al.
Supported by
A Journal of
Accepted Article
Title: Strong Influence of the Ancillary Ligand over the Photodynamic
Anticancer Properties of Neutral Biscyclometalated Ir(III)
Complexes Bearing 2-Benzoazole-Phenolates
Authors: Marta Martínez-Alonso, Natalia Busto, Larry Danilo Aguirre,
Leticia Berlanga, María del Carmen Carrión, José Vicente
Cuevas, Ana María Rodríguez, Arancha Carbayo, Blanca
Rosa Manzano, Enrique Ortí, Félix Ángel Jalón, Begoña
García, and Gustavo Espino
This manuscript has been accepted after peer review and appears as an
Accepted Article online prior to editing, proofing, and formal publication
of the final Version of Record (VoR). This work is currently citable by
using the Digital Object Identifier (DOI) given below. The VoR will be
published online in Early View as soon as possible and may be different
to this Accepted Article as a result of editing. Readers should obtain
the VoR from the journal website shown below when it is published
to ensure accuracy of information. The authors are responsible for the
content of this Accepted Article.
To be cited as: Chem. Eur. J. 10.1002/chem.201803784
Link to VoR: http://dx.doi.org/10.1002/chem.201803784
1 
 
Strong Influence of the Ancillary Ligand over the Photodynamic 
Anticancer Properties of Neutral Biscyclometalated Ir(III) Complexes 
Bearing 2-Benzoazole-Phenolates 
 
Marta Martínez-Alonso,$,[a] Natalia Busto,$,[a] Larry Danilo Aguirre,[d] Leticia Berlanga,[a] M. Carmen 
Carrión,[b] José V. Cuevas,[a] Ana M. Rodríguez,[b] Arancha Carbayo,[a] Blanca R. Manzano,[b] Enrique 
Ortí,[c] Félix A. Jalón,[b] Begoña García,*[a] and Gustavo Espino*[a] 
$ These authors contributed equally to the work. 
aDepartamento de Química, Facultad de Ciencias, Universidad de Burgos, Plaza Misael Bañuelos s/n, 
09001, Burgos, Spain. 
bDepartamento de Química Inorgánica, Orgánica y Bioquímica, Facultad de Químicas, Universidad de 
Castilla-La Mancha, Avda. Camilo J. Cela 10, 13071 Ciudad Real, Spain. 
cInstituto de Ciencia Molecular, Universidad de Valencia, Catedrático José Beltrán 2, 46980 Paterna, 
Spain. 
dFacultad de Ingeniería Eléctrica y Electrónica. Universidad Nacional de Ingeniería. Av. Túpac Amaru 
210, PE-LIMA 025, Lima, Perú. 
 
 
Keywords: Heteroleptic neutral Iridium(III) complexes / 2-arylazoles / phosphorescent complexes / 
Photodynamic therapy / Anticancer complexes. 
 
ABSTRACT 
In this paper we describe the synthesis, comprehensive characterization and biological and 
photocatalytic properties of two series of neutral Ir(III) biscyclometalated complexes of general 
formula [Ir(C^N)2(N^O)], where the N^O ligands are 2-(benzimidazolyl)phenolate-N,O (L1, 
series a) and 2-(benzothiazolyl)phenolate-N,O (L2, series b), and the C^N ligands are 2-
(phenyl)pyridinate or its derivatives. Complexes of types a and b exhibit dissimilar 
photophysical and biological properties. In vitro cytotoxicity tests conclusively prove that 
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derivatives of series a are harmless in the dark against SW480 cancer cells (colon 
adenocarcinoma), but express enhanced cytotoxicity versus the same cells after stimulation with 
UV or blue light. In contrast, complexes of type b show a very high cytotoxic activity in the 
dark, but low photosensitizing ability. Thus, the ancillary N^O ligand is the main factor in terms 
of cytotoxic activity both in the dark and upon irradiation. However, the C^N ligands play a key 
role regarding metal accumulation in cells. In particular, the complex of formula 
[Ir(dfppy)2(L1)] (dfppy = 2-(4,6-difluorophenyl)pyridinate) [3a] has been identified as both an 
efficient photosensitizer for 1O2 generation and a potential agent for photodynamic therapy. 
These capabilities are probably related to a combination of its notable cellular internalization, 
remarkable photostability, high photoluminescence quantum yield, and long triplet excited-state 
lifetime. Both types of complexes exhibit notable catalytic activity in the photooxidation of 
thioanisole and S-containing aminoacids with full selectivity. 
 
INTRODUCTION 
Light-mediated therapy or phototherapy (PT) is a clinically approved, minimally invasive 
chemotherapeutic protocol that can exert a very selective and controlled cytotoxic activity 
toward malignant cells. PT involves the administration of a photosensitizing chemical agent 
(photosensitizer, PS) which ideally shows negligible cytotoxicity in the absence of light. 
Subsequently, the PS is excited by irradiation with light to initiate a photochemical reaction that 
produces biologically active species at cytotoxic levels, which are able to damage cell bio-
targets and lead to cell death via apoptosis or necrosis.[1] Two types PT protocols or treatments 
are known depending on the mechanism of action of the specific PS:[2,3] 
(a) O2-dependent treatments, where the PS exerts its action by producing highly reactive 
oxygen species (ROS) from cellular O2. This kind of protocol is called photodynamic 
therapy (PDT) and is classified into type I processes when the PS produces oxygen radicals 
and other ROS through an electron transfer reaction, and type II when the PS generates the 
very reactive 1O2 from ground state 3O2 through an energy transfer process.[4] 
(b) O2-independent treatments, where the PS performs its biological activity either through 
direct electron transfer reactions from the excited state of the PS to cellular targets, or 
alternatively, through photoinduced dissociation/release of ligands/drugs from metal 
complexes or organic caging groups. The latter strategy is called photoactivated 
chemotherapy (PACT) and gives rise to chemotherapeutic agents with potential dual 
activity when both the free ligand and the metal fragment or organic caging exhibit 
cytotoxic action.[5,6] 
In particular, the more conventional O2-dependent type II-PDT strategy involves the 
combination of three essential and separately non-toxic components: a photochemically active 
drug (PS), light of suitable wavelength, and the O2 dissolved in the tissues.[7] 
Useful light in PDT must combine two requirements: efficiency in penetration of tissues and 
high ability in 1O2 generation. On the one hand, red and infrared lights penetrate more deeply 
through tissues than blue light and the region between 600 and 1200 nm is often called the 
optical window of tissue. On the other hand, wavelengths longer than 800 nm cannot generate 
1O2, since they have insufficient energy to initiate a photodynamic reaction.[8] 
Approved PDT agents are macrocyclic organic molecules (porphyrin-, phtalocyanine- and 
chlorin-based derivatives) that photo-induce the generation of 1O2 or ROS. Nevertheless, these 
PSs often suffer from different drawbacks, such as laborious synthetic and purification 
protocols, troublesome chemical modification, low water solubility, absence of light absorptions 
in the ideal wavelength range (vide infra) (e.g., Photofrin),[9] low efficiency under low O2 
10.1002/chem.201803784
Ac
ce
pt
ed
 M
an
us
cr
ip
t
Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
3 
 
concentrations,[10] and slow excretion that give rise to prolonged photosensitivity in the 
patients.[11] 
The ideal attributes desirable for an efficient photosensitizer (PS) for singlet oxygen (1O2) 
generation in the context of PDT are:[9,12,13] (1) strong light absorption ability, particularly in the 
wavelength range between 650 and 800 nm so that they can take advantage of the deeper tissue 
penetration of red light and infrared radiation, (2) high intersystem crossing efficiency, which 
favors high quantum yields in the formation of the PS triplet excited state, and consequently in 
the generation of 1O2 or ROS in water, (3) long PS triplet excited state lifetimes that make the 
bimolecular collision with 3O2 more probable, (4) an energy gap between the triplet excited state 
(T1) and the singlet ground state (S0) that exceeds the excitation energy to produce 1O2 from 3O2 
(the latter being 1268 nm = 0.98 eV), (5) low quenching rate of 1O2, since many 1O2 
photosensitizers can also efficiently deactivate 1O2 to 3O2, (6) good solubility and stability in 
physiological media and amphiphilic character to ensure cellular uptake, (7) selective 
accumulation in the cancer cells, negligible cytotoxicity in the dark, and non-mutagenic nature, 
(8) good photostability and stability against photooxidation by 1O2 to prevent degradation and 
loss of sensitizing ability, and finally (9) rapid excretion from the body. 
In general, phosphorescent biscyclometalated iridium(III) complexes display very interesting 
emission properties, e.g., high quantum yields, large Stokes shifts, long-lived phosphorescence, 
modular color-tuning possibilities, and good photostability. As a result, they are being studied in 
the development of solid-state lighting devices, such as organic light-emitting diodes 
(OLEDs)[14] and light-emitting electrochemical cells (LECs),[15,16] as biological imaging 
agents,[17] and as analytical probes.[18] In addition, they work as efficient PSs in singlet oxygen 
production and can be used as O2 probes,[19,20] as photodynamic anticancer agents,[21–30][31–33][34] 
and as catalysts in photooxidation reactions.[35] Previous reports have shown that 
biscyclometalated Ir(III) complexes with 2-(2-hydroxyphenyl)oxazole-based N^O ancillary 
ligands, similar to those used in this work, exhibit highly efficient phosphorescence.[36] 
With these precedents in mind, in this work we aimed to synthesize two series of neutral Ir(III) 
biscyclometalated complexes of general formula [Ir(C^N)2(N^O)], where the N^O ligands are 
2-(benzimidazolyl)phenolate-N,O (series a) and 2-(benzothiazolyl)phenolate-N,O (series b), 
and to assess their photophysical and anticancer properties and in particular their potential as 
PDT agents. An additional goal was to test their catalytic behavior in the photooxydation of 
thioanisol and S-containing aminoacids. 
RESULTS AND DISCUSSION 
Synthesis and Characterization 
The synthetic method and the molecular structures of the neutral complexes described herein are 
sketched in Scheme 1. The [Ir(C^N)2(N^O)] complexes (C^N = 2-(phenyl)pyridinato-C2,N 
(ppy), 2-(4-tolyl)pyridinato-C2,N (tolpy), and 2-(4,6-difluorophenyl)pyridinato-C2,N (dfppy); 
N^O = 2-(benzimidazolyl)phenolate-N,O (L1) and 2-(benzothiazolyl)phenolate-N,O (L2)) were 
prepared in two steps. In the first step the chloro-bridged dimeric iridium(III) complexes rac-
[Ir(C^N)2(µ-Cl)]2 (C^N = ppy, tolpy) were obtained by reacting IrCl3 hydrate and 2-
phenylpyridine (ppy-H) or 2-(p-tolyl)pyridine (tolpy-H) in 2-ethoxyethanol/water (3:1 v/v) 
under reflux according to the well-established protocols reported in the literature.[37,38] The rac-
[Ir(C^N)2(µ-Cl)]2 dimer with C^N = dfppy was prepared more efficiently by an adapted 
procedure using a microwave heating source. Then, the isolated dimeric starting materials were 
reacted with the corresponding pro-ligands HL1 and HL2 in the presence of Na2CO3 under 
refluxing 2-ethoxyethanol/water. Complex [1b] has been previously described by Li et al. and 
proposed as a phosphorescent Hg2+-selective chemodosimeter.[39] 
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The new compounds exhibit C1 molecular symmetry and helicoidal chirality due to the presence 
of three bis(chelate) ligands and so they were isolated as racemic mixtures (∆,Λ) of yellow 
([1a]‒[3a]) to red-orange ([1b]‒[3b]) solids in good yields and with good purity. The 
complexes are soluble in dimethylsulfoxide and other organic solvents, but insoluble in water. 
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Scheme 1. Synthesis and molecular structures of the neutral complexes [1a]‒[3a] and [1b]‒[3b], showing 
atom numbering scheme, abbreviations, and labels used throughout the whole text. Only Λ enantiomers 
are shown. 
 
The composition and molecular structure of all the complexes were determined by multinuclear 
NMR, IR, mass spectroscopy, and elemental analysis. Two-dimensional NMR experiments 
were used to identify the signals of all the nuclei in the 1H and 13C{1H} NMR spectra. 
The 1H, 13C{1H}, and 19F NMR spectra of the new complexes exhibit one set of peaks for each 
of the two inequivalent C^N ligands due to the asymmetric nature of the coordination 
environment around the metal. For instance, the 1H NMR spectra of complexes [2a] and [2b] 
display two singlets each, for the Me groups of tolpy, whilst the 19F NMR spectra of complexes 
[3a] and [3b] show two quartets, each corresponding to atoms labeled as F11 and F11’, and two 
triplets, each assigned to atoms F9 and F9’ of dfppy (Figure S1). The unequivocal assignation of 
all the signals in the 1H NMR and 19F NMR of some derivatives was possible owing to the 
observation of crucial interligand NOE cross peaks H6↔H12’↔Hm↔H6 and H6’↔H12, as well 
as interring NOE cross peaks H3↔H9, H3’↔H9’, H3↔F9 and H3’↔F9’ in the 2D NOESY and 
19F-1H HOESY spectra (see Figures S2 and S3). Additional features in the spectra of the new 
derivatives confirm the expected structures: (a) broad singlets around 13 ppm for the N−H 
protons of complexes [1a], [2a], and [3a]; (b) the shifting of the signals for the ancillary anionic 
ligands L1 and L2 with regard to the respective resonances of the protonated pro-ligands HL1 
and HL2, and (c) the absence of peaks for O−H groups. 
The FAB+ mass spectra of the six complexes show envelope peaks whose m/z ratio and isotopic 
distribution are compatible with the [M+H]+ or [M]+ cations. In addition, the [Ir(C^N)2]+ 
fragments are observed in all the spectra, confirming that the N^O ligands are more labile than 
the corresponding cyclometalated ligands. 
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Crystal Structure by X-ray Diffraction 
The crystal structure of [1b] has been previously reported.[39] Single crystals of [3a]x 0.25 
Me2CO suitable for X-ray diffraction analysis were obtained by slow diffussion of acetone into 
a methanol solution of this complex. [3a] crystallizes in the monoclinic space group P21/c with 
0.25 molecules of acetone. The ORTEP diagram for the asymmetric unit is depicted in Figure 1, 
whereas selected bond lengths and angles with estimated standard deviations are gathered in 
Table S1, and crystallographic refinement parameters are given in Table S2. The corresponding 
unit cell shows two pairs of the enantiomers (Λ and ∆). The iridium center displays a slightly 
distorted octahedral coordination geometry with the expected cis-C,C and trans-N,N mutual 
disposition for the dfppy ligands.[40] The Ir−Cdfppy and Ir−Ndfppy bond distances lie in the 
expected range typical of phenylpyridinate type ligands (very close to 2 Å).[41–46] The bond 
lengths for the ancillary ligand are significantly longer due to the strong trans influence exerted 
by the donor C atoms, Ir(1)−N(1) = 2.147(4) Å and Ir(1)−O(1) = 2.159(3) Å.[47,48] The bite angle 
for L1, N(1)−Ir(1)−O(1) = 84.0(1)º, is comparable to those previously reported for six-
membered N−Ir−O iridacycles in analogous derivatives,[39] and the C−Ir−N bite angles for the 
cyclometalated C^N ligands, C(35)−Ir(1)−N(4) and C(24)−Ir(1)-N(3), are also standard 
(~80º).[49,50] 
In the molecular structure of [3a] the H···H interligand distances (H6↔H12’↔Hm↔H6 and 
H6’↔H12, see Scheme 1 for numbering and Figure S4) are shorter than 3.7 Å. These 
measurements are in agreement with the observed NOE interactions in the 2D NOESY spectra, 
which have been used for the complete assignment of the 1H NMR resonances. 
The 3D crystal packing is stabilized by intermolecular hydrogen bonds, (N(2)−H(2A)···O(1) 
and C(9)−H(9)···F(3)), CH‒π contacts and offset π‒π stacking interactions between pairs of 
difluorophenyl and hydroxophenyl rings (see Tables S3-S5 and Figure S5). It is interesting to 
note that the same phenoxy ring exhibits a CH‒π contact on one side and a π‒π stacking 
interaction on the opposite site reflecting a possible synergistic effect as it has been previously 
reported from ab initio calculations.[51] 
 
Figure 1. ORTEP diagram for (∆)-[3a] forming the asymmetric unit of racemic [3a]. Thermal ellipsoids 
are shown at the 30% probability level. Selected bond lengths (Å) for the coordination polyhedron of [3a] 
are: Ir(1)−C(24) = 1.989(5); Ir(1)−C(35) = 2.002(5); Ir(1)−N(3) = 2.035(4); Ir(1)−N(4) = 2.036(4); 
Ir(1)−N(1) = 2.147(4); Ir(1)−O(1) = 2.159(3). 
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Electrochemical properties 
The redox potentials of complexes [1a]‒[3a] and [1b]‒[3b] were experimentally measured in 
acetonitrile solutions (3 × 10‒4 M) by cyclic voltammetry using [nBu4N][PF6] (0.1 M) as 
supporting electrolyte and glassy carbon as working electrode. Argon was bubbled through the 
solutions to displace oxygen. Potentials were referred to the ferrocene/ferrocenium (Fc/Fc+) 
couple. The anodic region of the corresponding voltammograms show irreversible or quasi-
reversible oxidation peaks between +0.45 and +0.83 V (see Table 1 and Figure 2), which are 
ascribed to the oxidation of the Ir(III)-phenoxy entities as discussed in depth below. Notably, 
small effects on the potential values are attributed to both the N^O and C^N ligands. 
The interpretation of the cathodic region provided the following trends: (a) all the compounds 
with ligand L1 (X = N−H) exhibit a totally irreversible weak peak between ‒2.30 and ‒2.40 V, 
in agreement with the instability of the respective reduced species (Figure S6); (b) another 
quasi-reversible peak is observed at ‒2.64, ‒2.70, and ‒2.46 V for compounds [1a], [2a], and 
[3a], respectively; (c) as for complexes of type b, they exhibit a single quasi-reversible 
reduction peak at lower potentials (‒2.27, ‒2.17, and ‒2.11 V) compared to their relatives of 
type a, in agreement with the stabilization of the lowest-unoccupied molecular orbital (LUMO) 
for type b derivatives as discussed below; (d) the dfppy cyclometalated ligand shifts 
significantly the reduction peaks to less cathodic potentials. 
Table 1. Cyclic voltammetric data referenced to Fc/Fc+ in acetonitrile solution (3 × 10‒4 M)[a] 
Compound Eox1/2 (V) Ered1/2 (V) ΔE1/2 (V)[b] 
[1a] 0.45 (qr) ‒2.64 (qr) 3.09 
[1b] 0.58 (ir) ‒2.27 (qr) 2.85 
[2a] 0.45 (qr) ‒2.70 (qr) 3.15 
[2b] 0.63 (qr) ‒2.17 (qr) 2.80 
[3a] 0.63 (ir) ‒2.46 (qr) 3.09 
[3b] 0.83 (ir) ‒2.11 (qr) 2.94 
[a] Measured using [nBu4N][PF6] (0.1 M) as supporting electrolyte and a scan rate of 0.1 V s‒1 (qr = quasi-reversible, 
ir = irreversible). ΔE1/2 = Eox1/2 ‒ Ered1/2. 
 
Figure 2. (a) Cyclic voltammograms of complexes [1a]‒[3b] in acetonitrile solution (3 × 10‒4 M), using 
[nBu4N][PF6] (0.1 M ) as supporting electrolyte. Scan rate of 0.1 V s‒1. (•) Indicates the starting (Ei) and 
final potential (Ef), Ei = Ef = ‒0.55 V (vs. Fc/Fc+), clockwise scan.  
• 
• 
• 
• 
• 
• 
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Photophysical properties 
Electronic absorption properties. The UV-vis absorption spectra and the absorption maxima 
data recorded for complexes [1a]‒[3a] and [1b]‒[3b] in deoxygenated acetonitrile (10‒5 M) at 
25 ºC are shown in Figure 3 and Table 2, respectively. All the complexes exhibit intense (ε > 
40000 M‒1·cm‒1) and broad absorption bands in the ultraviolet region below 300 nm, attributed 
to spin-allowed intraligand transitions (1IL) (π → π*) within the cyclometalated (N^C) and 
ancillary (N^O) ligands. The less intense absorption bands and shoulders recorded at λ > 350 
nm and weak absorptions extending into the visible region are assigned to spin-allowed singlet-
to-singlet metal-to-ligand charge transfer (1MLCT) transitions and spin-forbidden singlet-to-
triplet 3MLCT (dπ(Ir) → π*(N^C and N^O)) transitions, as well as spin-forbidden ligand-to-
ligand charge transfer (3LLCT) (πN^O → π*C^N) and ligand-centered (3LC) (π → π*) 
transitions.[52–56] Apart from the above-mentioned features common to all the complexes, some 
differences are found in the absorption spectra of these derivatives depending on the ancillary 
ligand. In particular, complexes [1a]‒[3a] bearing L1 show relative maxima in the 350‒390 nm 
range (9240 < ε < 11270 M‒1·cm‒1) and then a weak absorption between 430 and 500 nm, 
whereas complexes [1b]‒[3b] with L2 lack the relative maxima in the 350‒390 nm range but 
display a more intense absorption above 425 nm that introduces itself well into the visible (λ = 
450 nm with ε > 6000 M‒1·cm‒1). 
 
Figure 3. Overlaid UV-Vis absorption spectra of complexes [1a]‒[3a] and [1b]‒[3b] in deoxygenated 
acetonitrile (10‒5 M) at 25 ᵒC. 
Table 2. Wavelengths (λabs/nm) and molar extinction coefficients (ε/M‒1·cm‒1) at the absorption maxima 
in the UV-Vis spectra of complexes [1a]‒[3a] and [1b]‒[3b] measured in deoxygenated acetonitrile (10‒5 
M) at 25 ᵒC. 
[1a] [1b] [2a] [2b] [3a] [3b] 
λabs ε λabs ε λabs ε λabs ε λabs ε λabs ε 
261 46640 261 44270 266 41550 268 47930 256 42140 250 42580 
351 10830 - - 349 9410 - - 334 9710 - - 
390 11210 - - 388 9240 - - 385 11270 - - 
450[a] 2670 450a 6790 450a 1760 450a 6610 450a 1400 450a 6210 
[a] These wavelengths do not correspond to relative maxima but allow to compare the absorption at 450 nm. 
In addition, the UV-Vis absorption spectra of the Ir complexes (Figure S7) were recorded under 
the conditions used for the in cellulo studies (vide infra). Table S6 shows the respective molar 
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extinction coefficients recorded at the irradiation wavelengths used in the photo-cytotoxicity 
experiments, i.e.: UV (365 nm) and blue (460 nm). All the complexes bearing L2 as ancillary 
ligand display higher absorptivity in the blue light irradiation wavelenght (460 nm) than the 
complexes of series a, whereas absorptivity in UV light irradiation wavelength (365nm) cannot 
be used to differentiate between both series. 
Photoluminescence properties. The complexes with L1 exhibit green photoluminescence, 
whereas those complexes with L2 glow with orange light under UV radiation. The emission 
spectra of complexes [1a]‒[3a] and [1b]‒[3b] upon excitation at the respective wavelengths in 
deoxygenated acetonitrile at room temperature are shown in Figure 4 and the photophysical data 
are compiled in Table 3. In these conditions, all the complexes display broad emission bands, 
with emission maxima appearing in the range between 512 and 533 nm for [1a]‒[3a], and 
between 580 and 607 nm for [1b]‒[3b]. Hence, there is a strong dependence of the emission 
energy on the N^O ligand, the red shift observed on replacing L1 with L2 being tentatively 
explained as due to the lower electron-donor ability of the benzothiazole moiety in L2 compared 
with the benzimidazole unit in L1.[16] As discussed below, this leads to the stabilization of the 
LUMO and consequently to the reduction of the energy gap. In contrast, the effect of the C^N 
ligand on the emission wavelength is almost negligible when replacing ppy in [1a] and [1b] 
with tolpy in [2a] and [2b], respectively, or weak at the most when using dfppy ([3a] and [3b]) 
(Table 3). 
The photoluminescent quantum yields (PLQYs) of complexes [1a]‒[3a] are very high (75‒
95%) and better than that for their free ancillary pro-ligand HL1 (63%). In contrast, the PLQYs 
of complexes [1b]‒[3b] are comparatively lower (9‒30%), though they largely exceed the 
PLQY of free HL2 (0.2%). The luminescence lifetimes (τ1/2) of these phosphors in degassed 
acetonitrile at 25 ºC range between 308 and 748 ns. These long-lived excited states compare 
well with the respective values for other phosphorescent Ir(III) compounds,[10,57] which supports 
the triplet nature of the emission state and prognosticates an efficient photosensitization 
ability.[11] The photoluminescence spectra and τ1/2 of [3a] and [3b] were also recorded in 
deoxygenated H2O/DMSO (96:4) at room temperature (Figure S8). Solvatochromic effects were 
not observed for these derivatives, though the luminescence lifetimes undergo important 
changes in aqueous media (see Table 3). 
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Figure 4. Overlaid emission spectra of complexes [1a]‒[3a] and [1b]‒[3b] in deoxygenated acetonitrile 
(10‒5 M) at 25 ᵒC. Excitation wavelengths (λexc) are given in Table 3. 
Table 3. Photophysical data for complexes [1a]‒[3a] and [1b]‒[3b] in deoxygenated acetonitrile (10‒4 M) 
at 25 ᵒC. 
Compound λexc (nm) λem (nm), 298 K PLQY (%) τ1/2 (ns) 
λem 
(nm)[a] 
HL1 338 457 (blue) 63 3.9 - 
HL2 311 363 (UV) 0.2 < 1 - 
[1a] 420 533 (2.33 eV), green 95 578 - 
[1b][c] 469 605 (2.05 eV), orange 11 605 - 
[2a] 399 527 (2.35 eV), green 75 384 - 
[2b] 469 607 (2.04 eV), orange 9 748 - 
[3a] 399 512 (2.42 eV), green 85 366 (115[b]) 510 
[3b] 451 580 (2.14 eV), orange 30 308 (975[b]) 586, 613 
[a] Recorded in deoxygenated H2O/DMSO (96:4) (10‒5 M) at 298 K. [b] The τ1/2 values in brackets were 
recorded in deoxygenated H2O/DMSO (96:4) (10‒5 M) at 298 K. [c] Photophysical properties of [1b] 
have been previously measured by Li and coworkers[39] in different conditions (λem = 602 nm; PLQY = 
1.8% with reference to [Ru(bpy)3]2+; τ1/2 = 980 ns, for an air-equilibrated solution of [1b] (20 µM) in 
CH2Cl2 at r. t.). 
 
Theoretical Calculations 
To gain insight into the electrochemical and photophysical properties of these compounds, 
density functional theory (DFT) calculations were performed at the B3LYP/(6-
31G*+LANL2DZ) level on the molecular and electronic structures of the [Ir(C^N)2(N^O)] 
complexes in the presence of the solvent (acetonitrile). 
Figure 5 displays the contour plots and the energies computed for the frontier molecular orbitals 
(MOs) of [1a] and [1b], as representative examples, at their electronic ground state (S0) 
optimized geometries. The highest-occupied molecular orbital (HOMO) of both complexes is 
composed of a mixture of Ir(III) dπ orbitals (t2g) and π orbitals of the phenoxy fragment of the 
(N^O) ligand. This is in contrast with the HOMO composition found for the well-known 
iridium(III) cationic complexes of general formula [Ir(C^N)2(N^N)]+ (C^N = ppy; N^N = 
diimine), for which the HOMO results from a mixture of Ir(III) dπ orbitals (t2g) and π orbitals of 
the cyclometalating C^N ligands.[58–61] In contrast to the HOMO, significant differences are 
found between the LUMO of [1a] and [1b]. Whereas for complex [1a] the LUMO, and also the 
LUMO+1, resides on the C^N ligands, the LUMO of [1b] is mainly located on the N^O ligand 
and its topology corresponds to the LUMO of the free ligand. The topologies of the LUMO and 
LUMO+1 of [1a] actually correlate with those of the LUMO+1 and LUMO+2 of [1b], and the 
LUMO of [1b] is indeed analogous to the LUMO+2 of [1a] (Figure 5). Thus, the LUMO of the 
N^O ligand is strongly stabilized by 0.50 eV on going from [1a] to [1b]. This stabilization is 
likely due to the deficient electron donor ability of benzothiazole compared to benzimidazole, 
which in turn could be related to the weaker overlapping ability of the 3p orbital in the S atom 
of benzothiazole when compared with the 2p orbital of the N atom in benzimidazole. 
The trends discussed above for the HOMO and LUMO of [1a] and [1b] are also observed for 
complexes [2a] and [3a] compared with [2b] and [3b] (Figure S9), and explain the experimental 
redox properties. On the one hand, the stabilization of the HOMO and LUMO by 0.09‒0.12 and 
0.20‒0.27 eV, respectively, in passing from [1a]‒[3a] to [1b]‒[3b] justifies the higher oxidation 
potentials and the less negative reduction potentials measured for [1b]‒[3b] (Table 1). On the 
other hand, the different nature of the LUMO suggests that reduction takes place first on the 
C^N ligands for complexes [1a]‒[3a] and on the N^O ligand for [1b]‒[3b]. This has been 
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ascertained by computing the anion species of [1a] and [1b], for which the extra electron is 
located on the C^N and N^O ligand, respectively. The higher stabilization undergone by the 
LUMO determines that the HOMO−LUMO energy gap decreases from 3.48−3.51 eV in [1a]‒
[3a] to 3.33−3.42 eV in [1b]‒[3b] (Figure S9), in good agreement with the reduction of the 
electrochemical gap observed experimentally (Table 1). If the emitting triplet state T1 is in a 
first approach assumed as originating from the HOMO → LUMO excitation, the calculated 
HOMO−LUMO gaps support the red-shift observed experimentally for the emission bands on 
going from [1a]‒[3a] (λem = 512‒533 nm) to [1b]‒[3b] (λem = 580‒605 nm).  
 
 
Figure 5. Schematic representation showing the energies and the isovalue contour plots calculated for the 
frontier molecular orbitals of [1a] and [1b]. 
To investigate the nature of the electronic excited states participating in the absorption and 
emission processes, the low-lying excited states of all the complexes were calculated at the 
optimized geometries of the ground state (S0) using the time-dependent DFT (TD-DFT) 
approach. Table S7 summarizes the vertical excitation energies calculated for the first three 
singlets and triplets, together with their molecular orbital description and electronic nature. The 
transitions to the singlet states above 400 nm present a low total oscillator strength (f = 0.02‒
0.03) for complexes [1a]‒[3a], whereas the same transitions in complexes [1b]‒[3b] show a 
significantly higher oscillator strength (f = 0.11‒0.14). This explains the lower intensity 
observed in the UV-Vis spectra for complexes [1a]‒[3a] above 400 nm (Figure 3). Concerning 
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the triplets, the three first triplet states of complexes [1a], [2a], and [3a] result from a 
combination of the HOMO → LUMO, LUMO+1, and LUMO+2 excitations and are predicted 
very close in energy in an interval of only 0.05, 0.06, and 0.15 eV, respectively. All the three 
states exhibit a 3MLCT character, due to the participation of the Ir atom in the HOMO, mixed 
with 3LLCT character, associated to the HOMO → LUMO and LUMO+1 excitations, and also 
3LC character due to the HOMO → LUMO+2 excitation involving the N^O ligand (see Figure 
5). In contrast, for complexes [1b], [2b], and [3b] bearing the benzothiazole-based ligand L2, 
the low-lying triplet is well-separated by ~0.4 eV from the other triplet states and is mostly 
defined by the HOMO → LUMO excitation. Since this excitation mainly involves the N^O 
ligand (Figure 5), the T1 state shows a predominant 3LC nature with a small 3MLCT character. 
To get a deeper insight into the electronic nature of the emitting state, the lowest T1 and T2 
triplet states of complexes [1a]‒[3a] and the T1 state of [1b]‒[3b] were furthermore optimized 
at the spin-unrestricted UB3LYP level. Figure 6 displays the unpaired-electron spin-density 
distributions calculated for [1a] (T1 and T2) and [1b] (T1) at their optimized geometries as 
representative examples. Complexes with the same ancillary ligand display analogous spin-
density distributions (Figure S10). For complex [1a], T1 features a 3LC character with a spin-
density distribution mainly centered on the ancillary N^O ligand (~1.86 unpaired electrons) and 
a small contribution from the Ir-ppy environment (~0.14e), thus matching the topology of the 
HOMO → LUMO+2 LC excitation. In contrast, T2 shows a 3LLCT/3MLCT character, with a 
spin density spreading over the ppy-Ir environment (Ir 0.46e, C^N ligands 1.35e) and a little 
contribution of the N^O ligand (0.19e), mainly originating from the HOMO → LUMO 
LLCT/MLCT excitation. After full geometry relaxation, the T1 and T2 states are predicted to be 
almost isoenergetic (2.46 and 2.47 eV above S0, respectively), and emission could indeed take 
place either from T1 or T2. Similar relative energies are also obtained for T1 and T2 in [2a] (2.45 
and 2.48 eV) and [3a] (2.48 and 2.60 eV). For complexes [1b]‒[3b], the T1 triplet has no other 
triplet state close in energy and clearly shows a 3LC nature (Figure 6) with a spin-density 
distribution mainly centered on the ancillary ligand (~1.78e) and a small contribution on the Ir-
ppy environment (~0.22e). UB3LYP calculations therefore suggest that emission occurs from a 
triplet state with a predominant 3LC nature for complexes [1b]‒[3b], whereas it results from a 
combination of 3MLCT/3LLCT and 3LC states for complexes [1a]‒[3a]. The 3LC nature (lower 
participation of the metal atom) and the lower energy (~2.10 eV) predicted for the emitting T1 
triplet of complexes [1b]‒[3b] justifies the lower PLQYs recorded for these complexes (9‒30%) 
compared with complexes [1a]‒[3a] (75‒95%) (Table 3). 
 
Figure 6. Spin-density contours calculated for fully relaxed T1 and T2 states of complex [1a] and T1 state 
of complex [1b]. 
 
O2-sensitive photo-luminescence 
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The O2-sensitive photoluminescence of complexes [1a], [2a], and [3a] was visually proved by 
taking photographs of the corresponding deoxygenated solutions in acetonitrile (10‒4 M) under 
UV light (365 nm) in the dark (Figure S11a), followed by slow diffusion of air (1 min) and then 
air-bubbling (1 min). Initially, the deoxygenated solutions exhibit strong photoluminescence, 
but then, after air exposure, an incipient quenching is observed in the high zone of the vials 
going down throughout the solution as a result of O2 diffusion (Figure S11b), and finally a fast 
and dramatic switch off in the emission is witnessed after air-bubbling (Figure S11c). Then, the 
photoluminescence was switched on again by bubbling N2 through the solutions for 1 minute 
(Figure S11d). This result establishes the reversibility of the process and suggests the potential 
use of these derivatives as PDT agents. Figure 7 shows the complete process of 
photoluminescence decay for [2a] as a result of O2 diffusion during a period of 2 minutes. 
Consistently, the comparison of the photoluminescence emission spectra of complex [2a] in 
deoxygenated and oxygenated acetonitrile (10‒4 M) at 25 ºC displays a dramatic drop in the 
intensity of the emission band for the latter (Figure S12). Furthermore, the O2-sensitive nature 
of the emission process is consistent with a phosphorescent mechanism.[62] 
 
 
Figure 7. Sequence of photographs illustrating the quenching of photoluminescence under UV light (365 
nm) for a solution of complex [2a] in acetonitrile (10‒4 M) prepared under N2 atmosphere in glove box as 
a result of O2 diffusion during a period of 2 min. 
 
Determination of quantum yields for the generation of 1O2  
Before performing the photocytotoxicity and catalytic photooxidation studies, we investigated 
the ability of the ligands and Ir complexes to produce 1O2 and the quantum yields for its 
generation (φΔ) was calculated. Indeed, φΔ is the number of 1O2 molecules formed per absorbed 
photon and to determine this parameter we studied the kinetics of the photooxidation of 1,3-
diphenylisobenzofuran (DPBF) in terms of absorbance decrease at 410 nm as a function of 
irradiation time (λiir = 460 nm). The collected data – pairs yields a first order kinetic curve 
except for HL1, HL2, [1b] and [2b]. The kinetic constants (k) were obtained from the fitting of 
these kinetic traces to a single exponential equation (Figure S13). φΔ was calculated by 
comparison with a standard photosensitizer (methylene blue, MB), as follows: φΔ,comp = 
φΔ,MB·kcomp/kMB. Table 4 summarizes the obtained results. Interestingly, complexes [1a]‒[3a] 
containing L1 are the most efficient photosensitizers in the generation of 1O2. 
Table 4. Quantum yields for singlet oxygen generation (φΔ) for the different compounds used as 
photosensitizers in DMSO/H2O (60:40) 
Compound φΔ 
HL1  
HL2  
[1a] 1.05 ± 0.08 
[1b]  
[2a] 1.12 ± 0.07 
10.1002/chem.201803784
Ac
ce
pt
ed
 M
an
us
cr
ip
t
Chemistry - A European Journal
This article is protected by copyright. All rights reserved.
13 
 
[2b]  
[3a] 0.86± 0.06 
[3b] 0.78 ± 0.12 
MB 0.52ª 
ª Taken from ref: Chem. Commun., 2015,51, 10831-10834 
 
Biological Studies 
Cellular Uptake. The uptake of the ligands and their Ir(III) complexes in SW480 (colon 
adenocarcinoma) cells was investigated by bioimaging thanks to the emission properties of the 
complexes and by inductively coupled plasma mass spectrometry (ICP-MS). For the bioimaging 
approach, a microplate reader in phase contrast, blue, green and orange emission modes was 
used. None of the ligands were visualized inside the cells. By contrast, all of the Ir(III) 
complexes are successfully internalized in the cells (Figure 8). 
 
Figure 8. Example of the cellular uptake of Ir(III) complexes by SW480 cells. The images correspond to 
the uptake of complex [1b] at 50 μM within 10 minutes of incubation time. 
In order to quantify the cellular internalization of the studied complexes, SW480 cells were 
treated with a 5 µM solution of each of these compounds during 24 h and ICP-MS 
measurements were performed. Iridium cellular accumulation is shown in Figure 9. There are 
no significant differences between series a and b, whereas there are substantial differences as a 
function of the C^N ligands that seem to be responsible for the complexes cellular uptake. 
Complexes bearing dfppy are the most internalized and those with ppy the less internalized. 
According to recent reports in the literature, the cellular uptake of the PS depends not only on 
their net charge, but also on their charge distribution, lipophilicity and 3D structure.[63,64] Thus, 
it has been argued that positively charged PSs are attracted electrostatically to the vicinity of 
cell membranes by the negatively charged components of the phospholipid bilayer, so that it is 
only in the proximity of the membrane that hydrophobic interactions begin to operate favoring 
the uptake of compounds with low net charge. In particular all our complexes are neutral, which 
should be advantageous for their passive transport across membranes. However they exhibit 
different dipole moments according to theoretical calculations (see Table S8). Indeed, 
complexes with dfppy are more polar than their respective couples, which could facilitate the 
initial attraction to the proximity of cell membrane and might be related to their faster 
internalization in the SW480 cells. 
Interestingly, all the new Ir derivatives are more accumulated inside the cells than the well-
known anticancer agent cisplatin (CDDP). 
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Figure 9. Iridium accumulation in SW480 cells treated with 5 µM solutions of the studied 
complexes during 24 h. 
Cytotoxicity and Photocytotoxicity. The cytotoxicity of both ligands and the Ir(III) complexes 
was studied in SW480 cells by means of the MTT proliferation assay with 24 h of exposure 
time in the dark and after 5 minutes of irradiation with either UV (λ= 365 nm, 8 mW cm‒2) or 
blue light (λ= 460 nm, 5.5 mW cm‒2). The IC50 values are summarized in Table 5. 
 
Table 5. IC50 values in SW480 cells with 24 h of exposure time of the ligands and their Ir(III) complexes 
in the dark and after 5 min of irradiation with UV (λ= 365 nm, 8 mW cm‒2) or blue light (λ= 460 nm, 
5.5 mW cm‒2). 
Compound IC50 Dark (μM) IC50 UV light (μM) IC50 Blue light (μM) 
HL1 >100 >100 >100 
HL2 >100 37.1 ± 4.7 >100 
[1a] >100 82.4 ± 14.4 42.9 ± 5.4 
[1b] 7.4 ± 1.1 54.4 ± 10.2 7.7 ± 1.0 
[2a] >100 >100 50.0 ± 10.2  
[2b] 7.0 ± 0.5 >100 7.6 ± 1.1 
[3a] >100 17.1 ± 0. 9 26.5 ± 0.9 
[3b] 16.5 ± 5.7 46.5 ± 8.4 16.4 ± 0.70 
CDDP 38.6 ± 1.4   
 
In the dark, neither the ligands nor the complexes of series a, bearing L1 as the ancillary ligand, 
are cytotoxic. By contrast, the complexes of type b, with L2 as the ancillary ligand, are more 
cytotoxic than CDDP, even though the cellular accumulation after 24 h is low for some of them, 
i.e., [1b] and [2b] (see Figure 9). Besides, the cytotoxic potency of [2b] in the dark is higher 
than that of [3b] despite the lower cellular accumulation of the former. Therefore, we can 
conclude that cellular accumulation has only a relative effect on the cytotoxicity of our Ir 
complexes in the dark. In addition, the images recorded in a bioimaging microplate reader (Fig. 
S14) show that the emission pattern of the complexes inside the cells depends on their ancillary 
ligand.  Indeed, complexes of type b seem to be preferentially localized in the nucleus while 
complexes of type a do not manage to get into the nucleus remaining outside. Furthermore, 
complex [3b] exhibits a distribution pattern slightly different to that of [1b] and [2b], since it is 
equally distributed throughout the cell. Consequently, the different subcellular localization of 
these derivatives as a function of the O^N ligand, mainly, and the C^N ligand, in second place, 
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could decisively determine their biomolecular targets and therefore, to their cytotoxic potency in 
the absence of light. 
Now, if we observe the IC50 figures of series b under UV irradiation, we can verify that the 
cytotoxicity diminishes, such diminution being very sharp in the case of [2b]. As shown below, 
this behavior can be attributed to the release of the HL2 ligand, whose cytotoxicity is less than 
that of the corresponding complexes. However, under blue light irradiation the IC50 values 
reported for this series remain unaltered regarding the values in the dark, meaning that the less 
energetic blue irradiation does not affect the stability of the complex. 
Contrary to what has been observed with the complexes of series b, the complexes of series a 
are the most promising compounds for PDT purposes since all of them displayed negligible 
cytotoxicity in the dark that was significantly increased after UV and Vis irradiation. The most 
revealing result is that obtained for complex [3a] that not only enhanced its cytotoxic activity 
after irradiation with either UV or blue light, but also displayed higher activity than cisplatin 
(CDDP). Within the complexes of series a, [3a] is the most cytotoxic after irradiation, an 
outcome ascribable, in principle, to the greater internalization degree of this complex in the dark 
compared to [1a] and [2a] (Figure 9). Once inside the cell, the irradiation causes the cell death 
by a number of processes associated to PDT (but only for complexes of series a). 
To properly learn some of the possible factors involved, the quantum yield in the 1O2 generation 
(φΔ) can be considered. Table 4 shows that under Vis light, the efficiency in 1O2 generation is 
quite high for series a. Hence, there is a good correlation between photo toxicity and φΔ for 
complexes of type a and, as a consequence, the observed phototoxicity could be related to the 
production of 1O2 and other ROS. Nevertheless, the φΔ values obtained for one of the Ir(III) 
complexes bearing L2 ([3b]) are not in good agreement with the photo-cytotoxicity results (as it 
does not exhibited increased cytotoxic activity when irradiated at 460 nm) even though it is 
rather efficient in the generation of singlet oxygen. 
 
Stability studies 
In order to clarify whether the new Ir(III) complexes are the actual species responsible for the 
observed cytotoxicity or photocytotoxicity we analysed their stability in the dark, under 
irradiation and at different pH values. 
Stability in the dark. The stability of aqueous solutions of the ancillary pro-ligands (HL1 and 
HL2) and all the Ir(III) complexes in the dark was experimentally corroborated by absorbance 
spectroscopy, since no changes were recorded in the respective spectra for a week. 
Photostability. The photostability of ligands HL1 and HL2 and the respective Ir(III) complexes 
was studied by recording their absorbance spectra freshly prepared in aqueous solution and after 
5 min of irradiation with UV (λ= 365 nm, 8 mW cm‒2)  and blue light (λ= 460 nm, 5.5 mW cm‒
2). Complexes of series a are stable after both irradiation periods since no changes in their UV-
Vis spectra are observed, whereas the complexes of type b show variations in their spectra after 
UV light irradiation that suggest a certain degree of chemical evolution (Figures S15).  
To identify the products resulting from photodegradation, the photo-stability of complexes [3a] 
and [3b] in solution (3·× 10‒4 M, DMSO-d6) was studied by 1H NMR over a period of 16 h 
under irradiation (blue light, LED, λ = 460 nm, 24 W) in an open-air tube. Both complexes 
showed a remarkable photo-stability during the first 8 h, since the 1H NMR spectra of [3a] and 
[3b] remained essentially unchanged. However, incipient signals for the free ligand and the 
chloro-bridged Ir(III) dimer appeared after 12 h and are clearly visible after 16 h, giving 
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degradation values of 5 and 13% by integration for [3a] and [3b], respectively (Figures S16 and 
S17). 
Stability of [1a] as a function of pH. The stability of the model complex [1a] as a function of 
pH was studied by 1H NMR in the dark. Thus, the addition of an excess of NaOH over a 
solution of [1a] in DMSO-d6 produces the extinction of the N−H resonance and the shifting of 
most of the signals in agreement with the formation of the anionic species, [1a’]− (See Scheme 
S1 and Figures S18-S19). On the other side, the acidification of a solution of [1a] in DMSO-d6 
with DCl gave rise to a mixture between the non-emissive complex [Ir(ppy)2Cl(DMSO-d6)] and 
the blue-emissive pro-ligand HL1 (See Scheme S1 and Figures S20-S21). A similar acid-
induced degradation has been reported for neutral complexes of general formula 
[Ir(C^N)2(X^O)] (C^N = ppy or dfppy, X^O = picolinate or acetylacetonate).[41] Both processes, 
the acidic dissociation and the basic deprotonation, are reversible as it was shown by 
supplementary experiments. In addition, dramatic changes in the colour of the photo-
luminescent emission (λirr = 365 nm) resulted from either acidification or alkalization of [1a], 
due to the formation of HL1 (green to blue) or [1a’]− (green to orange), respectively. 
 
Ir(III)-promoted Photooxidation of thioanisole and S-containing aminoacids 
 
Aiming to get deeper into the mechanism of action of these derivatives, we studied their 
photocatalytic properties. Ir(III) tris- and bis-cyclometalated complexes are able to catalyze 
different photooxidation reactions[57,62,65,66] as a result of their ability to generate singlet oxygen 
(1O2) or superoxide (O2•−).[20,67] In particular, Aoki et al. have shown that the photooxidation of 
thioanisole is promoted by Ir(III) tris-cyclometalated complexes of the type [Ir(C^N)3] (C^N = 
phenylpyridinate ligands).[68] After confirming that our derivatives can generate 1O2 as well 
(vide supra), we decided to test their ability to photocatalyze the above-mentioned reaction. 
Thus, we monitored by 1H NMR the evolution of an oxygenated thioanisole solution (10 mM) 
in DMSO-d6/D2O (3:2) in the presence of complexes [1a]‒[3a] and [1b]‒[3b] (10‒2 mM) 
illuminated with a blue LED strip (λem = 460 nm) at room temperature. In all the experiments 
the corresponding sulfoxide (methylphenylsulfoxide, MPS) was obtained selectively and the 
conversion depends strongly on both the ancillary and the cyclometalated ligands. Thus, 
photocatalysts [3a] and [3b] gave the highest conversion values (66 and 94% after 18 h, 
respectively) (Table 6). 
Several control experiments were performed in order to delve into the nature of this reaction. In 
particular, the reaction was inhibited in the absence of Ir(III) PSs or light (see entries 9 and 10 in 
Table 6). Moreover, the reaction was also impeded when employing the free ligands or when 
using [3a] as potential PS but in the presence of NaN3 (1O2 quencher)[28] (see entries 7, 8, and 11 
in Table 6). All these results confirm the photocatalytic nature of this oxidation, the active role 
of the Ir(III) complexes as PSs and the key role of 1O2 as the actual oxidant. 
Table 6. Catalyst screening and control experiments in the photooxidation of 
thioanisole under an O2 atmosphere and blue-LED irradiation 
Ph
S
Me
Ph
S
MeO
1/2
 
O2,
 
Cat (0.1 mol %)
DMSO-d6/D2O (3:2)
rt, blue LED (24 W)
Me
S
PhO
R
S
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Entry Conditions (Cat / Light / Gas)[a] % Conv, 12 h (18 h)[b] 
1 [1a] / Blue Light / O2 31.1 (61.5) 
2 [1b] / Blue Light / O2 45.1 (61.3) 
3 [2a] / Blue Light / O2 31.1 (54.5) 
4 [2b] / Blue Light / O2 39.6 (47.2) 
5 [3a] / Blue Light / O2 49.5 (66.3) 
6 [3b] / Blue Light / O2 77.0 (94.0) 
7 HL1 / Blue Light / O2 4.5 
8 HL2 / Blue Light / O2 3.2 
9 No Cat / Blue Light / O2 0 
10 [3a] / No Light / O2 2.3 
11 [3a] / Blue Light / O2 / NaN3[c] 0 
[a] Thioanisole (10 mM), PS (10−2 mM, 0.1 mol %) in a mixture of DMSO-d6/D2O (0.5 
mL, 3:2) at room temperature, under a saturated atmosphere of either O2 or N2 and under 
irradiation with blue light (LED, λ = 460 nm) in a septum-capped tube. [b] Conversion 
yields were determined by 1H NMR analysis (see Figure S21S22) of the crude mixture as 
average values of two independent experiments. [c] NaN3 (11 mM). 
 
In addition, complexes [3a] and [3b] were selected to assess their catalytic activity in the 
photooxidation of the sulfur-containing aminoacids, L-methionine and L-cysteine. The 
conversion values (%), collected in Table 7, demonstrate that [3a] and [3b] are efficient 
promoters in the chemoselective oxidation of both aminoacids to methionine sulfoxide and 
cystine respectively. Control experiments in the absence of PS confirmed the photocatalytic role 
of the Ir(III) derivatives in these transformations, though in the case of the easily oxidized L-
cysteine, partial oxidation also takes place in the absence of PS. These results suggest a possible 
mechanism of action based on the photooxidation of proteins at least for [3a]. 
 
Table 7. Photooxidation of L-methionine or L-cysteine under an O2 atmosphere and 
blue-LED irradiation 
S
Me
COO
NH3
S
Me
COO
NH3
O
*
*
methionine sulfoxide
SS,SC
 + RS,SCL-methionine
*
SC
1/2
 
O2,
 
Cat (0.1 mol %)
DMSO-d6/D2O (3:2)
rt, blue LED (24 W)
 
S
H COO
NH3
cystine
L-cysteine
*
RC
1/2
 
O2,
 
Cat (0.1 mol %)
CD3SOCD3/D2O (1:10)
rt, blue LED (24 W)
S
OOC
NH3
*
S
COO
NH3
*
RC,RC  
Entry Substrate Conditions[a] % Conv, 12 h (18 h)[b] 
1 L-Met [3a] / Blue light / O2 48 (71) 
2 L-Met [3b] / Blue light / O2 100 
3 L-Met No Cat / Blue light / O2 0 
4 L-Cys [3a] / Blue light / O2 90 
5 L-Cys [3b] / Blue light / O2 82 
6 L-Cys No Cat / Blue light / O2 44 
[a] L-methionine/L-cysteine (10 mM), PS (10−2 mM, 0.1 mol %) in a mixture of DMSO-d6/D2O 
(0.5 mL, 3:2 or 1:10 respectively) at room temperature, under a saturated atmosphere of O2 and 
under irradiation with blue light (LED, λ = 460 nm) in a septum-capped tube. [b] Conversion 
yields were determined by 1H NMR analysis (see Figure S22S23) of the crude mixture as average 
values of two independent experiments. 
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Conclusions 
In the present paper, we disclose the synthesis and characterization of six neutral Ir(III) bis-
cyclometalated complexes with two N^O ligands (2-(benzimidazolyl)phenolate (L1) and 2-
(benzothiazolyl)phenolate (L2)) and three different cyclometalated ligands. We show that the 
photophysical and electrochemical properties of the described complexes depend preeminently 
on the N^O ligand with a minor influence corresponding to the cyclometalated ligand. For 
instance, the photoluminescent quantum yields are very high for those complexes with L1 and 
moderately high or low for those complexes with L2. Besides, the emission wavelengths of the 
Ir(III) complexes are also strongly dependent on the specific N^O ligand, so that L1 causes a 
marked blue-shift (between 68 and 80 nm) compared to L2 in the emission of their respective 
complexes. These effects are thoroughly explained from theoretical calculations. 
The in vitro cytotoxicity studies carried out with the described Ir(III) complexes on SW480 
(colon adenocarcinoma) cells demonstrate that derivatives of type a (with L1) and b (with L2) 
exhibit very different biological activities. In particular, complexes of type a are innocuous 
against SW480 cells in the dark but display enhanced cytotoxicity after irradiation with UV or 
blue light. Specifically, complex [3a] with 2-(4,6-difluorophenyl)pyridinate as the C^N ligand 
has been recognized as the most efficient photosensitizer for PDT, likely due to a combination 
of several properties, such as high cellular uptake, good photostability, high quantum yield, long 
triplet excited state lifetime, high ability for 1O2 production, and significant catalytic activity in 
the oxidation of S-containing L-amino-acids. On the contrary, complexes of type b are very 
cytotoxic in the dark likely owing to their subcellular localization, though they are inefficient PS 
agents for PDT due to their inefficiency in 1O2 production and poor photostability upon UV 
irradiation. Moreover, the results obtained in this work suggest that within these two series of 
complexes the ancillary ligand is the main factor affecting the cytotoxic activity whereas the 
C^N ligands seem to control their cellular uptake. 
To conclude, these compounds offer versatile properties as potential anticancer drugs and 
deserve deeper studies in order to better understand the strong effects on the anticancer 
properties derived from the subtle structural change in the O^N ligand. 
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EXPERIMENTAL PART 
General Methods and starting materials. 
Starting materials. IrCl3·xH2O was purchased from Johnson Mattey and used as received. The 
starting dimers [Ir(µ-Cl)(C^N)2]2 (C^N = 2-phenylpyridinate, ppy; 2-(p-tolyl)pyridinate, tolpy; 
2-(2,4-difluorophenyl)pyridinate, dfppy) were prepared according to the reported procedure.[38] 
The pro-ligands 2-phenylpyridine, 2-(p-tolyl)pyridine, 2-(2,4-difluorophenyl)pyridine, 2-(2-
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hydroxyphenyl)-1H-benzimidazole (HL1) and 2-(2-hydroxyphenyl)benzothiazole (HL2) were 
purchased from Sigma-Aldrich and used without further purification. Deuterated solvents 
(CD3SOCD3, THF-d8, CDCl3, D2O) were obtained from Euriso-top. Conventional solvents such 
as acetonitrile (Fisher Scientific or HPLC, Prolabo), diethyl ether (Fisher Scientific), acetone 
(Fisher Scientific) and 2-ethoxyethanol (Acros Organics) were degassed and in some cases 
distilled prior to be used. Tetrabutylammonium hexafluorophosphate ([nBu4N][PF6]) was 
purchased from Acros. 
Synthesis methods and characterization of complexes. All synthetic manipulations were 
carried out under an atmosphere of dry, oxygen-free nitrogen using standard Schlenk 
techniques. The solvents were dried and distilled under nitrogen atmosphere before use. 
Elemental analyses were performed with a Thermo Fisher Scientific EA Flash 2000 Elemental 
Microanalyzer. The analytical data for the new compounds were obtained from crystalline 
samples when possible. In some cases, the data were reasonably accurate, but in others the 
agreement of calculated and found values for carbon was > 0.4%, so that solvent molecules 
were introduced in the molecular formulae to improve agreement. IR spectra were recorded on a 
Jasco FT/IR-4200 spectrophotometer (4000–400 cm–1 range) with Single Reflection ATR 
Measuring Attachment. FAB(+) Mass spectra (position of the peaks in Da) were recorded with 
an Autospec spectrometer. The experimentally obtained m/z values are expressed in Da and the 
isotopic distribution matches that of calculated fragments. NMR samples were prepared under a 
nitrogen atmosphere by dissolving the suitable amount of compound in 0.5 mL of the respective 
oxygen-free deuterated solvent and the spectra were recorded at 298 K on a Varian Unity Inova-
400 (399.94 MHz for 1H; 376.29 MHz for 19F; 100.6 MHz for 13C). Typically, 1H NMR spectra 
were acquired with 32 scans into 32 k data points over a spectral width of 16 ppm. 1H and 
13C{1H} chemical shifts were internally referenced to TMS via the residual 1H and 13C signals 
of CHD2SOCD3 (δ = 2.50 ppm and δ = 39.52 ppm), CHCl3 (δ = 7.26 ppm and δ = 77.16 ppm), 
THF-d7 (δ = 1.72, 3.58 ppm and δ = 67.21, 25.31 ppm) for CD3SOCD3, CDCl3 and THF-d8, 
respectively, according to the values reported by Fulmer et al.[69] Chemical shift values (δ) are 
reported in ppm and coupling constants (J) in Hertz. The splitting of proton resonances in the 
reported 1H NMR data is defined as s = singlet, d = doublet, t = triplet, st = pseudotriplet, q = 
quartet, sept = septet, m = multiplet, bs = broad singlet. 2D NMR spectra such as 1H-1H 
gCOSY, 1H-1H NOESY, 1H-13C gHSQC and 1H-13C gHMBC were recorded using standard 
pulse sequences. The probe temperature (±1 K) was controlled by a standard unit calibrated 
with methanol as a reference. All NMR data processing was carried out using MestReNova 
version 10.0.2. 
X-ray Crystallography. A summary of crystal data collection and refinement parameters for 
[3a] are given in Table S2. A single crystal of [3a] was coated in high-vacuum grease, mounted 
on a glass fiber, and transferred to a Bruker SMART APEX CCD-based diffractometer 
equipped with a graphite monochromated Mo-Kα radiation source (λ = 0.71073 Å). The highly 
redundant datasets were integrated using SAINT[70] and corrected for Lorentz and polarization 
effects. The absorption correction was based on the function fitting to the empirical 
transmission surface as sampled by multiple equivalent measurements with the program 
SADABS.[71] 
The software package WINGX[72] was used for space group determination, structure solution, 
and refinement by full-matrix least-squares methods based on F2. A successful solution by 
direct methods provided most non-hydrogen atoms from the E-map. The remaining non-
hydrogen atoms were located in an alternating series of least-squares cycles and difference 
Fourier maps. All non-hydrogen atoms were refined with anisotropic displacement coefficients. 
Hydrogen atoms were placed using a “riding model” and included in the refinement at 
calculated positions. CCDC reference number for [3a] is 1857871. 
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Measurements of UV-vis Absorption and Luminescence Spectra 
UV-vis absorption spectra were recorded on a UVIKON XS UV-vis spectrophotometer, while 
excitation and emission spectra were recorded on a PTI Quanta Master TM spectrofluorometer 
from Photon Technology International equipped with a 75 W xenon short arc lamp and a model 
814PTM detection system. Felix32 software was used to collect and process fluorescence data. 
Samples of 10‒4 M solutions in CH3CN were prepared in a globe-box under nitrogen 
atmosphere and the solutions were kept under inert atmosphere in quartz cuvettes equipped with 
Teflon septum screw caps for all the luminescence measurements. The emission and excitation 
slit widths were either 1 or 3 nm, depending on the emission intensity of the compounds, to 
avoid saturation of the detector. All optical measurements were made at room temperature or 77 
K. 
The luminescence emission spectra were first recorded by exciting at the maximum absorption 
wavelength of the corresponding UV-Vis absorption spectra. Once the maximum emission 
wavelength is determined in this experiment, an excitation scan for this emission was carried 
out to determine the maximum excitation wavelength, which was used later on to obtain the 
optimized emission spectra. 
The emission quantum yield (PLQY or Φ) was calculated for each complex according to the 
equation:[73] 
Φs  = Φr × (Is/Ir) × (Ar/As) 
where Φs is the quantum yield of the sample, As and Ar are the absorbance of the sample and the 
reference at the excitation wavelength, and Is and Ir represent the points of maximum intensity 
in the corrected emission spectra. Φr is the quantum yield for the reference complex, 
[Ir(ppy)2(bpy)](PF6), which is assumed to be 7.07 in the experimental conditions.[74] 
For the determination of the luminescence lifetime of compound [1a], the fluorescence decay 
was measured on a Photon Technology International (PTI) Time Master fluorimeter equipped 
with a picosecond nitrogen laser and a wavelength selector that was used with the dye 2-(4-
biphenylyl)-6-phenylbezoxazole (PBBO). Astroboscopic detector was coupled to a Czerny-
Turner monochromator on the emission port. The system was connected to a PC via an Ethernet 
interface and governed via Felix32. The instrumental parameters used were as follows: λex = 
396 nm, λem = 534 nm, 300 channels, integration time = 50 µs, 15 averages per decay, 5 shots 
per channel, laser pulse frequency = 5 Hz, 1 nm excitation and emission slit widths, and a 
logarithmic collection step. 
Electrochemical measurements. Electrochemical measurements were performed using a 
customized SPELEC (DropSens) equipment, a commercial fully integrated synchronized 
spectroelectrochemical device that includes a bipotentiostat/galvanostat controlled by DropView 
(DropSens). All experiments were carried out using a three-electrode cell using a glassy carbon-
disc with a diameter of 3 mm as working electrode, a platinum-wire as auxiliary electrode, and a 
silver-wire pseudo-reference electrode. Oxygen was removed from the solution by bubbling 
argon for 10 minutes and keeping the current of argon along the whole experiment. The formal 
potentials were determined by cyclic voltammetry (CV), scanning the potential at a scan rate of 
0.1 V s−1. All potentials were referred to the redox pair ferrocene/ferrocenium (Fc/Fc+) took as 
internal standard. All voltammetric experiments were started and finished at a potential of −0.55 
V and performed in a clockwise direction. Acetonitrile solutions of the complexes (3·× 10−4 M) 
were used in the presence of [nBu4N][PF6] (0.1 M) as supporting electrolyte. 
Theoretical Calculations. Density functional theory (DFT) calculations were carried out with 
the D.01 revision of the Gaussian 09 package,[75] using the Becke’s three-parameter B3LYP 
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exchange-correlation functional,[76,77] together with the 6-31G(d) basis set for H, C, N, O, F, and 
S,[78,79] and the “double-ζ” quality LANL2DZ basis set for the Ir element.[80] The geometries of 
the singlet ground state (S0) and the lowest-energy triplet state (T1) were fully optimized without 
imposing any symmetry restriction. The geometries of the triplet states were calculated at the 
spin-unrestricted UB3LYP level with a spin multiplicity of 3. All the calculations were 
performed in the presence of the solvent (acetonitrile). Solvent effects were considered within 
the self-consistent reaction field (SCRF) theory using the SMD keyword that performs a 
polarized continuum model (PCM)[81] calculation using the solvatation model of Thrular et al.[82] 
Time-dependent DFT (TD-DFT) calculations of the lowest-lying 15 singlets and triplets were 
performed in the presence of the solvent at the minimum-energy geometry optimized for the 
ground state (S0). 
Determination of singlet oxygen generation The 1O2 generation was verified by monitoring 
the photooxidation of 1,3-diphenylisobenzofuran (DPBF, 97 %, Sigma Aldrich, USA) by 
absorbance measurements as a function of the irradiation time. The irreversible interaction of 
DPBF with 1O2 leads to a decrease in the absorbance of the DPBF band centered at 410 nm as a 
consequence of the 1,4-cycloaddition.[83] Stock solution of all the compounds, methylene blue 
(MB) used as standard and DPBF were freshly prepared in DMSO. The final concentration of 
all the compounds including the standard in the cuvette was 10 μM, and that of DPBF 50 μM in 
DMSO:H2O (60:40). The absorbance was first recorded in a double beam Evolution 300 UV-
Vis spectrophotometer (Thermo Scientific) and then after different times of irradiation with 
continuous aeration. The irradiation was performed by means of a Xenon short arc lamp (Ushio) 
with an intensity of 150 W, coupled with a monocromator fixed at 460 nm and slits at 5 nm. The 
decrease of the absorbance caused by photobleaching of DPBF was measured and corrected in 
all experiments.  
Cellular Imaging 
Approximately 1 × 104 SW480 colon adenocarcinoma cells were cultured in 200 μL Dulbecco’s 
Modified Eagle’s Medium per well supplemented with 10% fetal bovine serum and 1% 
amphotericin-penicillin-streptomycin solution (all from Sigma Aldrich) in 96-well plates and 
incubated at 37 °C under a 5% CO2 atmosphere. The cells were grown for 24h and then exposed 
to 50 μM of the studied compounds. Then, the cells were visualized in a Cytation 5 Cell 
Imaging Multi-Mode Reader (Biotek Instruments, USA) in phase contrast, blue, green and 
orange fluorescence emission with a 20× objective.  
Photocytotoxicity 
Approximately 1 × 104 SW480 colon adenocarcinoma cells were cultured in 200 μL Dulbecco’s 
Modified Eagle’s Medium per well supplemented with 10% fetal bovine serum and 1% 
amphotericin-penicillin-streptomycin solution (all from Sigma Aldrich) in 96-well plates and 
incubated at 37 °C under a 5% CO2 atmosphere. After 24h of incubation, the cells were exposed 
to different concentrations of the studied compounds and incubated for other 60 minutes. Then, 
the cells were irradiated during 5 minutes with UV light (at 365 nm, 8 mW cm‒2) or with blue 
light (at 460 nm, 5.5 mW cm‒2) and incubated again for other 24h. After that, cells were 
incubated with 100 µL of MTT (3-(4,5-dimethyltiazol-2-yl)-2,5-diphenyltetrazoliumbromide) 
(Sigma Aldrich) dissolved in culture medium (500 μg mL‒1) for a further period of 3 hours. At 
the end of the incubation, the formazan was dissolved by adding 100 μL of solubilizing solution 
(10% SDS, 0.01 M HCl) to each well. Absorbance was read after 18h of incubation at 590 nm 
in a microplate reader (Cytation 5 Cell Imaging Multi-Mode Reader (Biotek Instruments, USA). 
Four replicates per dose were included. The IC50 values were calculated from cell survival data 
using nonlinear regression of the GraphPadPrism Software Inc. (version 6.01) (USA). The IC50 
values are the mean of at least two independent experiments. 
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Cellular uptake 
SW480 cells were seeded in 12-well plates (1.5 × 105 cells/well) and grown for 24h. Then, cells 
were exposed to 5 μM of the studied metal complexes during 24h. Before analysis cells were 
washed three times with DPBS (Dulbecco’s Phosphate Buffered Saline), then they were 
trypsinized and centrifugated. The pellets were resuspended in 1 mL of DPBS. In each case, 10 
μL were used to count cells. Then, cells were digested for ICP-MS with 65% HNO3 during 24h. 
Finally, solutions were analyzed in a 7700 ICP-MS (Agilent Technologies). Data are reported as 
the mean ± the standard deviation (n = 3). 
Stability in the dark 
Aqueous solutions (15 µM) of every compound were prepared and monitored by UV-vis 
spectroscopy during a week while kept at room temperature and protected from light. No 
changes in the UV-vis spectra were observed. 
Photostability 
15 μM fresh aqueous solutions of the studied complexes were prepared. Their absorbance were 
monitored in a Hewlett-Packard 8453A (Agilent Technologies, Palo Alto, CA) photodiode array 
spectrophotometer fitted out with a Peltier temperature control system, at 25.0 °C. Then, the 
solutions were irradiated during 5 minutes with UV light (at 365 nm, 8 mW cm‒2) or with blue 
light (at 460 nm, 5.5 mW cm‒2). Absorbance spectra were collected after each irradiation period. 
Stability of [1a] as a function of pH 
Alkalization: An aqueous solution of NaOH (0.5 M, 1.4 µL) was added to a solution of [1a] (4 
mM, 0.5 mL) in DMSO-d6 and the evolution of the mixture was monitored by NMR during 30 
minutes. Then, an excess of NaOH (0.5 M, additional 1.6 µL) was added to the mixture. Finally, 
DCl (1 M in D2O, 3 µL) was added over the same NMR tube to check the reversibility of the 
process (Figures S18 and S19). 
Acidification: A solution of DCl (1 M in D2O, 3 µL) was added to a solution of [1a] (4 mM, 0.5 
mL) in DMSO-d6 and the evolution of the mixture was monitored by NMR. Finally, NaOH (0.5 
M aq. sol. in D2O, 20 µL) was added over the same NMR tube to check the reversibility of the 
process (Figures S20 and S21). 
General procedure for the catalytic photooxidation of thioanisole and L-aminoacids 
Aliquots of stock solutions of the S-containing substrate in D2O and the Ir(III) PS in DMSO-d6 
were added to a 5 mL test tube to achieve final concentrations of 10 mM (1 equiv) and 10‒2 
mM, (0.1 mol %, 10‒3 equiv) respectively in a mixture DMSO-d6/D2O (0.5 mL, 3:2 or 1:10 for 
cysteine). The test tube is capped with a septum and the mixture is saturated with an atmosphere 
of O2 using a needle and a balloon and then stirred at room temperature under irradiation with 
blue light at a distance of 4 cm from a flexible blue LED strip (AIGOSTAR MODEL SL02-
RGB, λ = 460 nm, 24 W, 600 lm, 150 LEDs, 5 m). Conversion yields were determined by 1H 
NMR analysis (see Figures S22 and S23) of the crude mixture as average values of two 
independent experiments. ESI MS spectra were recorded to confirm the identity of all the 
products. Methyl phenyl sulfoxide was obtained as a racemic mixture (enantiomers SS and RS), 
cystine was obtained as the (R,R) diastereomer, and methionine sulfoxide was obtained as a 1:1 
mixture of diastereoisomers which are epimers at the sulfur atom, that is (SS,SC) and (RS,SC). 
Overoxidation to the corresponding sulfone products (thioanisole or methionine) or cysteine 
sulfenic, sulfinic or sulfonic acids were not detected in any experiment. NaN3 was added in the 
respective control experiments to achieve a final concentration of 11 mM. A turbid suspension 
was obtained after stopping the reaction for cystine. 
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